ProSciento to Present at the American Diabetes Association 79th Scientific Sessions Read More »
ProSciento’s Chief Medical Officer Dr. Linda Morrow to Present at 3rd Annual NASH Summit Read More »
View Our Presentation
Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease: A Focus on Early Phase Clinical Drug Development Read More »
Sotagliflozin Decreases Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption Read More »
Pharmacokinetic and pharmacodynamic differences of new generation, longer-acting basal insulins: potential implications for clinical practice in type 2 diabetes Read More »
